Development and validation of a low-cost, open-source robotic extrusion printing platform for acellular hydrogel scaffold fabrication: A step toward multi-axis robotic bioprinting

Commercial multi-axis robotic bioprinting platforms remain prohibitively expensive for many laboratories, limiting access to robot-assisted biofabrication. This study converted a low-cost six-axis industrial robot (ABB IRB 120T with IRC5 Compact controller) into an open-source robotic extrusion printing platform and compared its dimensional performance with a commercial robotic bioprinter (BioAssemblyBot 400). Validation was limited to acellular hydrogel and planar toolpaths; cell-laden and non-planar printing remain necessary for biological validation. The platform integrated a modified printhead, elevated glass print bed, solenoid-based extrusion control, and a software pipeline that translated slicer-generated G-code into ABB RAPID motion and I/O commands. Five scaffolds were printed using the developed platform and three using the commercial system with a 4% alginate–4% carboxymethylcellulose bioink. The retrofitted platform demonstrated higher repeatability, with a mean coefficient of variation of 2.25% and maximum dimensional range of 0.388 mm, compared with 5.07% and 1.130 mm for the commercial system. Scaffold-level analysis (n = 5 vs. n = 3) showed significantly lower macro-scale dimensional variance for the retrofitted system, while pore-scale variance was lower but not statistically significant. No statistically significant difference between platforms was detected for overall-dimension or Y-direction pore-width accuracy, whereas the retrofitted system showed better X-direction pore-length accuracy in the pooled analysis. The total development cost was $16,617, an 89.6% reduction relative to the commercial system. These findings demonstrate a technically viable, substantially lower-cost pathway to multi-axis robotic biofabrication, with remaining dimensional limitations likely tied to bioink processing and the absence of crosslinking rather than robotic motion control.

Authors

Institutions

Publication Details

Journal
International Journal of Bioprinting
Published
2026-11-18
DOI
https://doi.org/10.36922/ijb026330352
Primary Topic
3D Printing in Biomedical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and validation of a low-cost, open-source robotic extrusion printing platform for acellular hydrogel scaffold fabrication: A step toward multi-axis robotic bioprinting

Ahasan Habib, Perrin Woods, Kenneth Houston
3 links
International Journal of Bioprinting
3D Printing in Biomedical Research
article

Development and validation of a low-cost, open-source robotic extrusion printing platform for acellular hydrogel scaffold fabrication: A step toward multi-axis robotic bioprinting

Ahasan Habib, Perrin Woods, Kenneth Houston
article en

Abstract

Commercial multi-axis robotic bioprinting platforms remain prohibitively expensive for many laboratories, limiting access to robot-assisted biofabrication. This study converted a low-cost six-axis industrial robot (ABB IRB 120T with IRC5 Compact controller) into an open-source robotic extrusion printing platform and compared its dimensional performance with a commercial robotic bioprinter (BioAssemblyBot 400). Validation was limited to acellular hydrogel and planar toolpaths; cell-laden and non-planar printing remain necessary for biological validation. The platform integrated a modified printhead, elevated glass print bed, solenoid-based extrusion control, and a software pipeline that translated slicer-generated G-code into ABB RAPID motion and I/O commands. Five scaffolds were printed using the developed platform and three using the commercial system with a 4% alginate–4% carboxymethylcellulose bioink. The retrofitted platform demonstrated higher repeatability, with a mean coefficient of variation of 2.25% and maximum dimensional range of 0.388 mm, compared with 5.07% and 1.130 mm for the commercial system. Scaffold-level analysis (n = 5 vs. n = 3) showed significantly lower macro-scale dimensional variance for the retrofitted system, while pore-scale variance was lower but not statistically significant. No statistically significant difference between platforms was detected for overall-dimension or Y-direction pore-width accuracy, whereas the retrofitted system showed better X-direction pore-length accuracy in the pooled analysis. The total development cost was $16,617, an 89.6% reduction relative to the commercial system. These findings demonstrate a technically viable, substantially lower-cost pathway to multi-axis robotic biofabrication, with remaining dimensional limitations likely tied to bioink processing and the absence of crosslinking rather than robotic motion control.

International Journal of BioprintingVol. 0(0)
Rochester Institute of Technology (US)
Industry, innovation and infrastructure
3D Printing in Biomedical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon